More on AUPH

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.7 Score)
- Holders

Upcoming Events

- Earnings (7/31/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Aurinia Pharmaceuticals (NQ:AUPH)
Delayed: 14.32 -0.42 (2.85%)
Prev. Close $14.74  
Open$14.50 
52 Wk High$5.69 
52 Wk Low$1.42 
Day High$14.56 
Day Low$13.98 
P/E N/A  
EPS$0.00 
Volume992,717 


Mar 3, 2026 05:35 PM Form 4 Aurinia Pharmaceuticals For: Feb 27 Filed by: TANG KEVIN
Mar 3, 2026 05:30 PM Form SCHEDULE 13D/A Aurinia Pharmaceuticals Filed by: TANG CAPITAL MANAGEMENT LLC
Mar 3, 2026 04:19 PM Form 4 Aurinia Pharmaceuticals For: Feb 27 Filed by: Donley Matthew Maxwell
Mar 3, 2026 04:19 PM Form 4 Aurinia Pharmaceuticals For: Feb 27 Filed by: Robertson Stephen P.
Mar 3, 2026 04:19 PM Form 4 Aurinia Pharmaceuticals For: Feb 27 Filed by: Miller Joseph M
Mar 3, 2026 04:19 PM Form 4 Aurinia Pharmaceuticals For: Feb 27 Filed by: Keenan Greg
Mar 3, 2026 04:19 PM Form 4 Aurinia Pharmaceuticals For: Feb 27 Filed by: Greenleaf Peter
Feb 26, 2026 06:12 AM Form 10-K Aurinia Pharmaceuticals For: Dec 31
Feb 26, 2026 06:12 AM Form 8-K Aurinia Pharmaceuticals For: Feb 26
Feb 26, 2026 06:06 AM Aurinia Pharmaceuticals (AUPH) Tops Q4 EPS by $1.38, provides guidance
View All Articles

Entities mentioned with AUPH

View All Entities